Digital Support for Multiple Myeloma Quality of Life
NCT07642362 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 108
Last updated 2026-06-11
Summary
The objective of this prospective study is to investigate the quality of life of patients with multiple myeloma and the effectiveness of support provided through a personalized web-based platform.
Specifically, the study will compare Patient-Reported Outcomes (PROs) and the associated improvement in side effects and quality of life achieved through appropriate personalized educational and supportive content.
Conditions
- Multiple Myeloma
- Patient Reported Outcome (PRO)
- Supportive Care in Cancer
- Quality of Life
Interventions
- BEHAVIORAL
-
Digital support
Personalized educational and supportive material, based on each patients' adverse events reported as PROs, delivered via the online platform.
Sponsors & Collaborators
-
Μedical Association for the Study of Cancer Biology and Treatments (Μ.Α.S.CA.B.T.)
collaborator UNKNOWN -
CareAcross
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-02-27
- Primary Completion
- 2028-03-31
- Completion
- 2028-03-31
Countries
- Greece
Study Locations
More Related Trials
-
Multiple Myeloma (MM) Quality of Life (QOL) Study
NCT04388735 ·Status: UNKNOWN
-
Patient and Care Partner Experiences Living With Multiple Myeloma (PaCE-MM)
NCT05276622 ·Status: TERMINATED
-
Moving Forward With Myeloma: A Lifestyle Intervention for Individuals With Multiple Myeloma
NCT07236502 ·Status: RECRUITING ·Phase: NA
-
The Myeloma Pack: A Multi-Modality Educational Intervention Strategy to Engage Patients With Multiple Myeloma
NCT03777306 ·Status: COMPLETED ·Phase: NA
-
Autologous Transplantation for Multiple Myeloma
NCT00378222 ·Status: COMPLETED ·Phase: PHASE3
-
Early Palliative Care for Patients With Multiple Myeloma and Aggressive Lymphoma
NCT06485076 ·Status: RECRUITING ·Phase: NA
-
The Burden of Multiple Myeloma on Patients and Caregivers Quality of Life: a Canadian Real-World Study
NCT06610045 ·Status: COMPLETED
-
Evaluating the Impact of a 12-month Multi-Modal Lifestyle Management Intervention on Disease Relevant Biomarkers
NCT06987708 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Non-chemotherapeutic Interventions for the Improvement of Quality of Life and Immune Function in Patients With Multiple Myeloma
NCT05312255 ·Status: RECRUITING ·Phase: NA
-
A Machine Learning Approach to Connect Multiple Myeloma Complexity to Early Disease Recurrence
NCT06767254 ·Status: RECRUITING
-
Chemotherapy, Stem Cell Transplantation and Donor and Patient Vaccination for Treatment of Multiple Myeloma
NCT00006184 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma
NCT06297226 ·Status: RECRUITING ·Phase: PHASE2
-
Nonmyeloablative Allogeneic Stem Cell Transplant Followed by Bortezomib in High-risk Multiple Myeloma Patients
NCT02308280 ·Status: COMPLETED ·Phase: PHASE2
-
Chemotherapy, Vaccine Therapy, and Stem Cell Transplantation in Patients With Newly Diagnosed Multiple Myeloma
NCT00024466 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Impacts on Health Outcomes and Resources Utilization of Hospital-at-home for Elderly Patients With Multiple Myeloma
NCT03490084 ·Status: UNKNOWN
-
Quality of Life and Treatment Outcomes in RRMM Patients Receiving Advanced vs. Conventional Immunotherapies
NCT07051850 ·Status: RECRUITING
-
Impact of Paramedical Consultations in Oncological Supportive Care in Outpatients With Multiple Myeloma
NCT05355987 ·Status: COMPLETED ·Phase: NA
-
A Dietary Study for People With Multiple Myeloma
NCT07226609 ·Status: RECRUITING ·Phase: NA
-
Integrative Multi-omics Analysis to Predict Monoclonal Gammopathies Clinical Evolution
NCT07214324 ·Status: RECRUITING
-
Clinical Outcomes and Prognostic Factors in Multiple Myeloma Patients
NCT06457464 ·Status: NOT_YET_RECRUITING
-
Stem Cell Translpantation in Multiple Myeloma
NCT05082675 ·Status: COMPLETED ·Phase: PHASE2
-
Autologous Stem Cell Transplantation for Myeloma Patients Over 65 Years
NCT01671826 ·Status: UNKNOWN
-
Clinical Decision-making, Prognosis, Quality of Life and Satisfaction in Relapsed/Refractory Multiple Myeloma
NCT03190525 ·Status: ACTIVE_NOT_RECRUITING
-
Home Treatment With Carfilzomib in Patients With Multiple Myeloma
NCT05620238 ·Status: COMPLETED
-
A Study of Bortezomib as Consolidation Therapy in Patients With Multiple Myeloma
NCT00416273 ·Status: COMPLETED ·Phase: PHASE3